New: NCI-funded clinical trial search
Mednet Logo
CommunityNeurology

How do you decide between Vyalev and Onapgo for patients who would benefit from continuous dopaminergic stimulation?

Related previous discussion on theMednet on Vyalev.
1 Answer
Mednet Member
Neurology · SUNY Downstate Health Sciences University
Answered on

Either is fine.

Join for free or sign in to see the full answer